Research reportEffects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys
References (16)
- et al.
Dihydrexidine, a novel selective high potency full D1 receptor agonist
Eur. J. Pharmacol.
(1989) - et al.
Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum
Eur. J. Pharmacol.
(1991) - et al.
Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys
Behav. Brain Res.
(1994) - et al.
Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys
Brain Res.
(1990) - et al.
Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low-dose MPTP-treated monkeys
Brain Res.
(1993) - et al.
Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys
Pharmacol. Biochem. Behav.
(1994) - et al.
Dopamine receptors labeled by [3H]quinpirole
Eur. J. Pharmacol.
(1991) - et al.
Dihydroxidene, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys
Eur. J. Pharmacol.
(1991)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1994 Published by Elsevier B.V.